← back to search

Oliver Popp

Max Delbrück Center · DE
Area of research
Cell Biology · Molecular Biology
Research interest
Research focused on Ubiquitin and Carcinogenesis, with related work in Ubiquitin ligase, Glutamine, Cell biology. Notable publications include 'The tRNA methyltransferase Dnmt2 is required for accurate polypeptide synthesis during haematopoiesis', 'YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer', and 'Sequential Poly-ubiquitylation by Specialized Conjugating Enzymes Expands the Versatility of a Quality Control Ubiquitin Ligase'.
h-index
citations
757
works
22
NIH funding
primary concept
email

Recent publications

Systematic evaluation of neoepitope predictions challenges clinically observed T-cell responses and their impact on immune evasion
Journal for ImmunoTherapy of Cancer 2026cited by 1position: middledoi
Autophagy selectively clears ER in TNF-α-induced muscle atrophy
Autophagy Reports 2026cited by 1position: middledoi
Multicenter Longitudinal Quality Assessment of MS-Based Proteomics in Plasma and Serum
Journal of Proteome Research 2025cited by 11position: middledoi
Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark set
Nature Communications 2025cited by 6position: middledoi
Intestinal interstitial fluid isolation provides novel insight into the human host-microbiome interface
Cardiovascular Research 2025cited by 3position: middledoi
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities
Nature Cancer 2024cited by 26position: middledoi
K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors
Life Science Alliance 2024cited by 22position: middledoi
Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder
Brain Behavior and Immunity 2023cited by 44position: middledoi
Small molecule inhibiting microglial nitric oxide release could become a potential treatment for neuroinflammation
PLoS ONE 2023cited by 11position: middledoi
Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda <i>et al</i>
Journal for ImmunoTherapy of Cancer 2023cited by 2position: middledoi
Identification of tumor-specific MHC ligands through improved biochemical isolation and incorporation of machine learning
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 2position: middledoi
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
Nature Communications 2022cited by 66position: middledoi
H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2<sup>+</sup> patients with diffuse midline glioma
Journal for ImmunoTherapy of Cancer 2022cited by 23position: middledoi
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma
Cancer Immunology Research 2022cited by 15position: middledoi
A member of the tryptophan-rich protein family is required for efficient sequestration of Plasmodium berghei schizonts
PLoS Pathogens 2022cited by 14position: middledoi
YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer
Cancer Research 2021cited by 83position: middledoi
A Universal Peptide Matrix Interactomics Approach to Disclose Motif-Dependent Protein Binding
Molecular & Cellular Proteomics 2021cited by 18position: middledoi
The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
Oncogene 2021cited by 14position: middledoi
Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models
Molecular Cancer 2021cited by 10position: middledoi
Sequential Poly-ubiquitylation by Specialized Conjugating Enzymes Expands the Versatility of a Quality Control Ubiquitin Ligase
Molecular Cell 2016cited by 83position: middledoi
Loss of DJ-1 impairs antioxidant response by altered glutamine and serine metabolism
Neurobiology of Disease 2016cited by 70position: middledoi
The <scp>tRNA</scp> methyltransferase Dnmt2 is required for accurate polypeptide synthesis during haematopoiesis
The EMBO Journal 2015cited by 232position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Philipp Mertins · Abterra Biosciences (United States)13 papers (2021–2026)Gunnar Dittmar · Charité - Universitätsmedizin Berlin5 papers (2015–2022)Wolfgang Walther · German Cancer Research Center3 papers (2021–2022)Thomas Blankenstein · Helmholtz Association of German Research Centres3 papers (2022–2023)Mohamed Haji · Max Delbrück Center3 papers (2021–2026)Helmut Kettenmann · Shenzhen University2 papers (2023–2023)Daniel Pérez-Hernández · Max Delbrück Center2 papers (2021–2021)Shima Mecklenbräuker · Humboldt-Universität zu Berlin2 papers (2023–2026)George Papafotiou · German Cancer Research Center2 papers (2022–2023)Thomas Sommer · Max Delbrück Center2 papers (2016–2024)Ulrike Stein · German Cancer Research Center2 papers (2021–2021)Lena Immisch · Gesellschaft für Fertigungstechnik und Entwicklung2 papers (2022–2023)Evelyn Ramberger · Alacris (Germany)2 papers (2021–2022)Lars Bullinger · University of Gothenburg2 papers (2022–2022)Mathias Dahlmann · German Cancer Research Center2 papers (2021–2021)Susanne A. Wolf · Helmholtz Association of German Research Centres2 papers (2023–2023)Gerald Willimsky · Charité - Universitätsmedizin Berlin2 papers (2022–2023)Martin G. Klatt · German Cancer Research Center2 papers (2023–2026)Lena Wedeken · University of Tübingen1 papers (2021–2021) · 1 papers (2022–2022)